Skip to main content
. 2015 Mar 26;10(3):e0116693. doi: 10.1371/journal.pone.0116693

Table 2. Patient characteristics at baseline.

Characteristic Intervention group (n = 161) Control group (n = 168)
Sociodemographic characteristics
Mean age, years ± SD 75.2 ± 6.0 75.6 ± 6.0
Male sex, n (%) 101 (62.7) 103 (61.3)
Living alonea, n (%) 42 (26.8) 44 (26.4)
School education a > 9 years, n (%) 45 (29.6) 32 (19.4)
Risk factors and comorbidities
Diabetes mellitus, n (%) 45 (28.0) 61 (36.3)
Congestive heart failure, n (%) 48 (29.8) 47 (28.0)
Blood pressure, mean ± SD a
  Systolic BP, mmHg 121.6 ± 13.7 124.2 ± 13.5
  Diastolic BP, mmHg 71.4 ± 7.8 71.3 ± 8.3
Hyperlipidaemia, n (%) 79 (49.1) 84 (50.0)
BMI (kg/m2), mean (SD)* 27.7 ± 4.2 27.3 ± 3.9
Smokinga, n (%)
    Current smoker 21 (13.6) 19 (11.5)
    Ex-smoker 76 (49.4) 67 (40.4)
    Never-smoker 57 (37.0) 80 (48.2)
AMI characteristics and treatment, n (%)
Re-infarction 33 (20.5) 41 (24.4)
ST-segment elevation MI 68 (43.6) 50 (30.3)
Non-ST-segment elevation MI 71 (45.5) 95 (57.6)
Bundle branch block 17 (10.9) 20 (12.1)
Any reperfusion treatment 140 (87.0) 141 (83.9)
Coronary artery bypass grafting 26 (16.2) 24 (14.3)
PCI without stenting 4 (2.5) 9 (5.4)
PCI with stenting 112 (69.6) 113 (67.3)
Any in-hospital complication a , b 31 (19.5) 26 (15.5)
Cardiac rehabilitation in the first 3 months a 68 (54.4) 84 (52.8)
Physical/mental health, mean ± SD a
HAQ-DI Score 0.8 ± 0.8 0.8 ± 0.8
IADL-Score 5.6 ± 1.6 5.6 ± 1.5
MMST 26.7 ± 4.1 26.4 ± 3.8
GDS 3.2 ± 3.1 3.2 ± 2.6
Social support 3.9 ± 0.6 3.9 ± 0.6
WHO-5-Well-Being Index 13.6 ± 6.8 13.2± 6.9

a n (%) refer to non-missing observations

b Includes pulmonary oedema, re-infarction, bradycardia, ventricular tachycardia and cardiogenic shock

*BMI: Body Mass Index